Phase
Condition
Kidney Cancer
Renal Cell Cancer
Renal Cell Carcinoma
Treatment
N/AClinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
people with stage cT1 renal tumors confirmed by preoperative CT or MR
people who are proposed to undergoing partial nephrectomy
localized renal tumors without lymph node and distant metastases as defined by NCCNguidelines
ECOG score of 0 or 1
Life expectancy greater than 10 years
Exclusion
Exclusion Criteria:
people with surgically unresectable lesions
people with Abnormal preoperative renal function, eGFR(estimated byCKD-EPI)<90ml/min/1.73m2
people who receive preoperative molecular targeted therapy, immunotherapy,chemotherapy
people with any contraindications to surgery
people who convert to radical nephrectomy during surgery
people who receive molecular targeted therapy, immunotherapy or chemotherapy duringthe postoperative follow-up period
people with serious systemic disease
Study Design
Study Description
Connect with a study center
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
Nanjing, Jiangsu 210000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.